Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 08/05/21
Amarin to Report Second Quarter and Six Month 2021 Financial Results and Host Conference Call on August 5, 2021GlobeNewsWire • 07/15/21
Amarin Corporation plc (AMRN) CEO John Thero Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/08/21
Further Insights into Mechanism of Action of Icosapent Ethyl and Its Unique Form of Eicosapentaenoic Acid (EPA) Presented at the European Atherosclerosis Society (EAS) Congress 2021GlobeNewsWire • 06/02/21
Amarin Corporation's (AMRN) CEO John Thero on Jefferies Virtual Healthcare Conference - TranscriptSeeking Alpha • 06/02/21
Amarin Highlights Multiple Scientific Findings for VASCEPA® (Icosapent Ethyl) and Its Unique Active Ingredient at the American College of Cardiology's 70th Annual Scientific SessionGlobeNewsWire • 05/17/21
REDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent Ethyl)-Driven Serum Eicosapentaenoic Acid (EPA) Levels Suggest Potential Benefit in New Heart Failure in Studied At-Risk Patients as Presented at the American College of Cardiology's 70th Annual SciGlobeNewsWire • 05/15/21
Clinical Data and Other Research Results Regarding VASCEPA® (Icosapent Ethyl) and Its Unique Active Ingredient to Be Presented at the American College of Cardiology's 70th Annual Scientific SessionGlobeNewsWire • 05/04/21
Amarin Corporation PLC (AMRN) CEO John Thero on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/29/21
Amarin Reports First Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 04/29/21
Amarin Announces Planned Retirement of Joseph T. Kennedy, EVP, General CounselGlobeNewsWire • 04/29/21